US Stock MarketDetailed Quotes

BioCryst Pharmaceuticals (BCRX)

Watchlist
  • 8.940
  • +0.180+2.05%
Close Apr 24 16:00 ET
  • 8.700
  • -0.240-2.68%
Post 19:51 ET
2.27BMarket Cap7.39P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals (BCRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
94.10%874.84M
209.09%406.56M
36.14%159.4M
49.41%163.35M
56.89%145.53M
36.00%450.71M
40.83%131.53M
34.98%117.09M
32.54%109.33M
34.87%92.76M
Operating revenue
94.10%874.84M
209.09%406.56M
36.14%159.4M
49.41%163.35M
56.89%145.53M
36.00%450.71M
36.58%131.53M
36.65%117.09M
32.54%109.33M
34.87%92.76M
Cost of revenue
55.47%19.08M
56.25%9.52M
-31.89%2.19M
64.69%2.8M
261.11%4.57M
173.80%12.27M
318.26%6.09M
182.66%3.21M
78.84%1.7M
34.86%1.27M
Gross profit
95.18%855.76M
216.51%397.03M
38.05%157.21M
49.17%160.56M
54.07%140.97M
34.11%438.44M
36.43%125.44M
33.02%113.87M
32.00%107.63M
34.87%91.5M
Operating expense
16.73%514.77M
5.16%136.65M
20.19%127.62M
32.26%130.77M
12.98%119.74M
2.40%440.99M
-3.47%129.95M
8.87%106.18M
-3.30%98.87M
10.11%105.98M
Selling and administrative expenses
30.90%348.65M
18.97%95.78M
27.52%83.01M
42.67%87.38M
38.62%82.47M
24.42%266.35M
24.70%80.51M
28.54%65.1M
20.10%61.25M
24.28%59.49M
Research and development costs
-4.87%166.13M
-17.34%40.87M
8.57%44.6M
15.32%43.39M
-19.84%37.27M
-19.36%174.64M
-29.42%49.44M
-12.37%41.08M
-26.58%37.62M
-3.92%46.49M
Operating profit
13,508.93%340.99M
5,876.06%260.39M
284.70%29.59M
239.98%29.79M
246.51%21.23M
97.55%-2.54M
89.44%-4.51M
164.52%7.69M
142.32%8.76M
49.01%-14.49M
Net non-operating interest income expense
18.58%-68.2M
46.14%-11.25M
17.96%-17.42M
9.98%-19.07M
0.02%-20.47M
9.40%-83.77M
-3.78%-20.88M
8.31%-21.24M
15.84%-21.18M
14.75%-20.48M
Non-operating interest income
-27.65%10.67M
-19.05%2.89M
-37.68%2.24M
-29.21%2.52M
-24.98%3.02M
-6.53%14.75M
-20.04%3.57M
-14.17%3.59M
-5.23%3.55M
19.33%4.03M
Non-operating interest expense
-19.94%78.87M
-42.19%14.14M
-20.81%19.66M
-12.74%21.58M
-4.13%23.49M
-8.98%98.52M
-0.55%24.45M
-9.20%24.83M
-14.46%24.73M
-10.55%24.51M
Other net income (expense)
-741.50%-5.39M
-85.93%-1.12M
-138.78%-38K
-4,940.48%-4.23M
101.96%1K
97.87%-641K
-61.50%-604K
113.30%98K
99.71%-84K
77.73%-51K
Gain on sale of security
76.29%-152K
79.30%-125K
-64.29%35K
25.00%-63K
101.96%1K
38.31%-641K
-61.50%-604K
113.30%98K
-127.91%-84K
77.73%-51K
Special income (charges)
---17.33M
---10.42M
---2.74M
---4.17M
----
--0
--0
--0
--0
----
-Less:Other special charges
--17.33M
--10.42M
--2.74M
--4.17M
----
----
----
----
----
----
Other non- operating income (expenses)
--12.09M
--9.42M
--2.67M
----
----
----
----
----
----
----
Income before tax
407.51%267.39M
1,054.24%248.02M
190.21%12.13M
151.88%6.49M
102.16%758K
61.56%-86.95M
58.85%-25.99M
62.46%-13.45M
83.24%-12.5M
33.51%-35.01M
Income tax
83.19%3.53M
170.15%2.17M
-231.23%-769K
714.53%1.4M
98.90%726K
521.61%1.93M
156.18%804K
77.58%586K
-76.76%172K
-45.60%365K
Net income
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
Net income continuous Operations
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
Minority interest income
Net income attributable to the parent company
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
396.87%263.86M
1,017.50%245.85M
191.92%12.9M
140.12%5.09M
100.09%32K
60.77%-88.88M
56.59%-26.8M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
Basic earnings per share
393.02%1.26
1,000.00%1.17
185.71%0.06
133.33%0.02
0
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
39.29%-0.17
Diluted earnings per share
381.40%1.21
961.54%1.12
185.71%0.06
133.33%0.02
0
63.56%-0.43
58.06%-0.13
63.16%-0.07
85.00%-0.06
39.29%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 94.10%874.84M209.09%406.56M36.14%159.4M49.41%163.35M56.89%145.53M36.00%450.71M40.83%131.53M34.98%117.09M32.54%109.33M34.87%92.76M
Operating revenue 94.10%874.84M209.09%406.56M36.14%159.4M49.41%163.35M56.89%145.53M36.00%450.71M36.58%131.53M36.65%117.09M32.54%109.33M34.87%92.76M
Cost of revenue 55.47%19.08M56.25%9.52M-31.89%2.19M64.69%2.8M261.11%4.57M173.80%12.27M318.26%6.09M182.66%3.21M78.84%1.7M34.86%1.27M
Gross profit 95.18%855.76M216.51%397.03M38.05%157.21M49.17%160.56M54.07%140.97M34.11%438.44M36.43%125.44M33.02%113.87M32.00%107.63M34.87%91.5M
Operating expense 16.73%514.77M5.16%136.65M20.19%127.62M32.26%130.77M12.98%119.74M2.40%440.99M-3.47%129.95M8.87%106.18M-3.30%98.87M10.11%105.98M
Selling and administrative expenses 30.90%348.65M18.97%95.78M27.52%83.01M42.67%87.38M38.62%82.47M24.42%266.35M24.70%80.51M28.54%65.1M20.10%61.25M24.28%59.49M
Research and development costs -4.87%166.13M-17.34%40.87M8.57%44.6M15.32%43.39M-19.84%37.27M-19.36%174.64M-29.42%49.44M-12.37%41.08M-26.58%37.62M-3.92%46.49M
Operating profit 13,508.93%340.99M5,876.06%260.39M284.70%29.59M239.98%29.79M246.51%21.23M97.55%-2.54M89.44%-4.51M164.52%7.69M142.32%8.76M49.01%-14.49M
Net non-operating interest income expense 18.58%-68.2M46.14%-11.25M17.96%-17.42M9.98%-19.07M0.02%-20.47M9.40%-83.77M-3.78%-20.88M8.31%-21.24M15.84%-21.18M14.75%-20.48M
Non-operating interest income -27.65%10.67M-19.05%2.89M-37.68%2.24M-29.21%2.52M-24.98%3.02M-6.53%14.75M-20.04%3.57M-14.17%3.59M-5.23%3.55M19.33%4.03M
Non-operating interest expense -19.94%78.87M-42.19%14.14M-20.81%19.66M-12.74%21.58M-4.13%23.49M-8.98%98.52M-0.55%24.45M-9.20%24.83M-14.46%24.73M-10.55%24.51M
Other net income (expense) -741.50%-5.39M-85.93%-1.12M-138.78%-38K-4,940.48%-4.23M101.96%1K97.87%-641K-61.50%-604K113.30%98K99.71%-84K77.73%-51K
Gain on sale of security 76.29%-152K79.30%-125K-64.29%35K25.00%-63K101.96%1K38.31%-641K-61.50%-604K113.30%98K-127.91%-84K77.73%-51K
Special income (charges) ---17.33M---10.42M---2.74M---4.17M------0--0--0--0----
-Less:Other special charges --17.33M--10.42M--2.74M--4.17M------------------------
Other non- operating income (expenses) --12.09M--9.42M--2.67M----------------------------
Income before tax 407.51%267.39M1,054.24%248.02M190.21%12.13M151.88%6.49M102.16%758K61.56%-86.95M58.85%-25.99M62.46%-13.45M83.24%-12.5M33.51%-35.01M
Income tax 83.19%3.53M170.15%2.17M-231.23%-769K714.53%1.4M98.90%726K521.61%1.93M156.18%804K77.58%586K-76.76%172K-45.60%365K
Net income 396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M
Net income continuous Operations 396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M
Minority interest income
Net income attributable to the parent company 396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 396.87%263.86M1,017.50%245.85M191.92%12.9M140.12%5.09M100.09%32K60.77%-88.88M56.59%-26.8M61.18%-14.03M83.17%-12.67M33.66%-35.38M
Basic earnings per share 393.02%1.261,000.00%1.17185.71%0.06133.33%0.02063.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.0639.29%-0.17
Diluted earnings per share 381.40%1.21961.54%1.12185.71%0.06133.33%0.02063.56%-0.4358.06%-0.1363.16%-0.0785.00%-0.0639.29%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -